Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.28 EUR | +1.07% | +7.27% | +25.28% |
Apr. 11 | Recticel Secures SBTi Validation for Net-zero Targets | MT |
Feb. 29 | Recticel SA/NV Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company is in a robust financial situation considering its net cash and margin position.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 35.89 times its estimated earnings per share for the ongoing year.
- The company is highly valued given the cash flows generated by its activity.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+25.28% | 792M | B- | ||
+5.92% | 104B | A- | ||
-2.51% | 64.55B | A- | ||
+51.90% | 41.5B | B | ||
+18.29% | 40.01B | B | ||
+7.47% | 33.03B | A- | ||
+10.70% | 20.11B | B- | ||
+16.99% | 17.52B | C+ | ||
+20.27% | 15.51B | B- | ||
+10.05% | 15.34B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- RECT Stock
- Ratings Recticel NV